Federal grants support PDE4 programs in neurological disease

NIDA and the Department of Defense supported studies in substance use disorders and multiple sclerosis.

Previous
Previous

Fannin Partners Secures Grant Funding from NIDA and DoD to Advance Novel PDE4B Inhibitors for Neurological Diseases

Next
Next

11h data presented at the ISAM World Congress